INTERNATIONAL PATENT: PFIZER INC., RIPARIAN PHARMACEUTICALS, INC. FILES APPLICATION FOR "KLF2 INDUCING COMPOUNDS AND USES THEREOF"

GENEVA, Feb. 17 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192), RIPARIAN PHARMACEUTICALS, INC. (201 Dexter AvenueWatertown, Massachusetts 02472) filed a patent application (PCT/IB2024/057466) for "KLF2 INDUCING COMPOUNDS AND USES THEREOF" on Aug 01, 2024. With publication no. WO/2025/032440, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SERRANO-WU, Michael (4 Elizabeth RoadBoston, Massachusetts 02478), TUTTLE, Jamison Bryce (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139), WESTER, R...